Company attributes
Venture Capital Firm attributes
Other attributes
BVF Partners L.P. is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments.
Since its inception in 1993, Biotechnology Value Fund has worked to build concentrated, long-term investments in small-capital biotechnology companies while performing rigorous diligence and on-going monitoring of their investments.
Biotechnology Value Fund commits to working with their portfolio companies as partners in their success. Their investments include Syndax Pharmaceuticals, Revolution Medicines, Phathom Pharmaceuticals, Vividion Therapeutics, Prevail Therapeutics, Peloton Therapeutics, Relay Therapeutics and Akero Therapeutics.